Advertisement

Topics

Centrexion Therapeutics, Corp. Company Profile

12:02 EDT 18th June 2019 | BioPortfolio

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and aims to develop new, safer and more effective therapies that overcome the limitations and challenges associated with current pain treatments. Founded by world-renowned leaders in drug development and well-funded by key investors, Centrexion Therapeutics is building a pain treatment powerhouse to address the substantial and growing global chronic pain epidemic. Centrexion Therapeutics has recently relocated from Baltimore, Md. to Boston, Mass.


News Articles [931 Associated News Articles listed on BioPortfolio]

Lilly Licenses Centrexion Non-Opioid Pain Candidate for Up to $1B

Eli Lilly said it has acquired exclusive worldwide rights to the non-opioid pain candidate CNTX-0290 from Centrexion Therapeutics, in a deal that could generate up to about $1 billion, plus royalties,...

Eli Lilly In-Licenses Non-Opioid Drug from Centrexion in $997 Million-Plus Deal

Eli Lilly announced it has inked a license agreement with Centrexion Therapeutics to acquire the exclusive global rights to CNTX-0290.

Centrexion completes enrolment in Phase III CNTX-4975 trial

Centrexion Therapeutics has completed patient enrolment ahead of schedule in the Phase III VICTORY-1 trial assessing the safety and efficacy...Read More... The post Centrexion completes enrolment in P...

Centrexion's non-opioid pain candidate acquired by Lilly

Centrexion Therapeutics granted Eli Lilly exclusive global rights to its early-stage non-opioid pain candidate CNTX-0290 for  -More- 

Lilly licenses non-opioid pain candidate from Centrexion; PDV near $1bn

Eli Lilly & Co. licensed exclusive global rights to develop and sell the non-opioid pain candidate CNTX0290 from Centrexion Therapeutics Corp.

Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller

Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics. Ad...

Lilly to Acquire Exclusive Worldwide Rights for Centrexion’s Investigational Non-Opioid Pain Asset CNTX-0290

INDIANAPOLIS, May 28, 2019 /PRNewswire/ — Eli Lilly and Company(NYSE: LLY) today announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therape...

Lilly licenses non-opioid pain therapeutic from Centrexion

Eli Lilly has signed an agreement to license exclusive global rights for non-opioid pain asset CNTX-0290 from biopharmaceutical company Centrexion...Read More... The post Lilly licenses non-opioid pai...

PubMed Articles [473 Associated PubMed Articles listed on BioPortfolio]

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Clinical Trials [180 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1377 Associated Companies listed on BioPortfolio]

Centrexion Therapeutics Corp.

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest, exclusively pain-focused pipelines of non-opioid, n...

Centrexion Therapeutics, Corp.

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-...

Centrexion Therapeutics

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutic...

Centrexion Therapeutics Corporation

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-o...

InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

More Information about "Centrexion Therapeutics, Corp." on BioPortfolio

We have published hundreds of Centrexion Therapeutics, Corp. news stories on BioPortfolio along with dozens of Centrexion Therapeutics, Corp. Clinical Trials and PubMed Articles about Centrexion Therapeutics, Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Centrexion Therapeutics, Corp. Companies in our database. You can also find out about relevant Centrexion Therapeutics, Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...


Corporate Database Quicklinks



Searches Linking to this Company Record